Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update
CPIX Stock | USD 1.37 0.26 23.42% |
Slightly above 72 percent of all Cumberland Pharmaceuticals' investors are curious in acquiring. The analysis of overall sentiment of trading Cumberland Pharmaceuticals stock suggests that a large number of investors are confidant at this time. Cumberland Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Cumberland Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Cumberland |
Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that its portfolio of FDA-approved brands delivered combined revenues of 9.1 million during the third quarter of 2024. The company ended the third quarter of 2024 with 77 million in total assets, 52 million in liabilities and 25 million of shareholders equity.
Read at finance.yahoo.com
Cumberland Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cumberland Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cumberland Pharmaceuticals Fundamental Analysis
We analyze Cumberland Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cumberland Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cumberland Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Cumberland Pharmaceuticals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Cumberland Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cumberland Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cumberland Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cumberland Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Cumberland Pharmaceuticals Related Equities
PROC | Procaps Group | 53.68 | ||||
CPHI | China Pharma | 5.26 | ||||
AKAN | Akanda Corp | 4.94 | ||||
IRWD | Ironwood Pharmaceuticals | 4.26 | ||||
PRFX | Painreform | 1.10 | ||||
LFCR | Lifecore Biomedical | 0.81 | ||||
KMDA | Kamada | 0.17 | ||||
EVOK | Evoke Pharma | 0.46 | ||||
ORGO | Organogenesis Holdings | 1.52 | ||||
IXHL | Incannex Healthcare | 1.62 | ||||
RGC | Regencell Bioscience | 1.80 | ||||
SHPH | Shuttle Pharmaceuticals | 2.30 | ||||
BFRI | Biofrontera | 2.94 | ||||
PTPI | Petros Pharmaceuticals | 6.90 |
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.